FDA Inspection 877763 — LEO Pharma Ireland
The FDA completed an inspection of LEO Pharma Ireland on Mar 14, 2014 in Dublin 12. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 14, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 12 (Ireland)